BRISTOL-MYERS SQUIBB COMPANY Proceeds from Issuance or Sale of Equity
BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Proceeds from Issuance or Sale of Equity of $782.00 million for the 9-month period ending 2009-09-30, per its 10-Q filed 2009-10-22.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOrSaleOfEquity · last filed 2009-10-22
- BRISTOL-MYERS SQUIBB COMPANY proceeds from issuance or sale of equity for the quarter ending 2009-09-30 was $0.00.
- BRISTOL-MYERS SQUIBB COMPANY proceeds from issuance or sale of equity for the quarter ending 2008-09-30 was $0.00.
| Period end | Proceeds from Issuance or Sale of Equity 3 month | Proceeds from Issuance or Sale of Equity 6 month | Proceeds from Issuance or Sale of Equity 9 month |
|---|---|---|---|
| 2009-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-22 | $782.00M 10-Q · filed 2009-10-22 | |
| 2009-06-30 | $782.00M 10-Q · filed 2009-07-23 | ||
| 2008-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-22 | $0.00 10-Q · filed 2009-10-22 | |
| 2008-06-30 | $0.00 10-Q · filed 2009-07-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |